Micke O - Search Results

1

CA 19-9 in the therapy monitoring and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapy.

Micke O, Bruns F, Schäfer U, Kurowski R, Horst E, Willich N. Micke O, et al. Anticancer Res. 2003 Mar-Apr;23(2A):835-40. Anticancer Res. 2003. PMID: 12820309 Clinical Trial.

2

Accelerated radiochemotherapy in pancreatic cancer is not necessarily related to a pathologic pancreatic function decline in the early period.

Horst E, Seidel M, Micke O, Rübe C, Glashörster M, Schäfer U, Willich NA. Horst E, et al. Among authors: micke o. Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):304-9. doi: 10.1016/s0360-3016(01)02594-9. Int J Radiat Oncol Biol Phys. 2002. PMID: 11872274

3

The clinical value of squamous cell carcinoma antigen in patients irradiated for locally advanced cancer of the head and neck.

Micke O, Bruns F, Schäfer U, Horst E, Büntzel J, Willich N. Micke O, et al. Anticancer Res. 2003 Mar-Apr;23(2A):907-11. Anticancer Res. 2003. PMID: 12820321

4

Adjuvant radiotherapy in locally confined prostate cancer.

Schäfer U, Witt F, Micke O, Willich N. Schäfer U, et al. Among authors: micke o. Anticancer Res. 2003 Mar-Apr;23(2A):983-5. Anticancer Res. 2003. PMID: 12820335

5

Carcinoembryonic antigen (CEA)--a useful marker for the detection of recurrent disease in endometrial carcinoma patients.

Bruns F, Micke O, Halek G, Schäfer U, Willich N. Bruns F, et al. Among authors: micke o. Anticancer Res. 2003 Mar-Apr;23(2A):1103-6. Anticancer Res. 2003. PMID: 12820355

6

Predictive value of carbohydrate antigen 19-9 in pancreatic cancer treated with radiochemotherapy.

Micke O, Bruns F, Kurowski R, Horst E, deVries AF, Hausler JW, Willich N, Schäfer U. Micke O, et al. Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):90-7. doi: 10.1016/s0360-3016(03)00524-8. Int J Radiat Oncol Biol Phys. 2003. PMID: 12909220 Clinical Trial.

7

Results and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapy.

Micke O, Hesselmann S, Bruns F, Horst E, Devries A, Schüller P, Willich N, Schäfer U. Micke O, et al. Anticancer Res. 2005 May-Jun;25(3A):1523-30. Anticancer Res. 2005. PMID: 16033054 Free article.

8

The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy.

Micke O, Bruns F, Schäfer U, Prott FJ, Willich N. Micke O, et al. Anticancer Res. 2005 May-Jun;25(3A):1663-6. Anticancer Res. 2005. PMID: 16033078 Free article.

9

The use of prostate-specific antigen (PSA) for the monitoring of radiation therapy in prostate cancer.

Schäfer U, Micke O, Hampel G, Brandt B, Bovenschulte A, Semjonow A, Willich N. Schäfer U, et al. Among authors: micke o. Anticancer Res. 1997 Jul-Aug;17(4B):2983-6. Anticancer Res. 1997. PMID: 9329581

10

Prostate-specific antigen (PSA) and radiotherapy in locally confined prostate cancer.

Schaefer U, Micke O, Willich N. Schaefer U, et al. Among authors: micke o. Anticancer Res. 1999 Jul-Aug;19(4A):2645-8. Anticancer Res. 1999. PMID: 10470211

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

251 results

Search Page

Filters